Sonoma Pharmaceuticals, Inc. (SNOA) Reaches $2.73 After 6.00% Down Move; Barometer Capital Management Boosted Sun Life Financial (SLF) Stake

June 18, 2018 - By Dolores Ford

Sun Life Financial Inc. (NYSE:SLF) Logo

Barometer Capital Management Inc increased Sun Life Financial Inc (SLF) stake by 47.19% reported in 2018Q1 SEC filing. Barometer Capital Management Inc acquired 220,437 shares as Sun Life Financial Inc (SLF)’s stock declined 0.82%. The Barometer Capital Management Inc holds 687,524 shares with $28.27M value, up from 467,087 last quarter. Sun Life Financial Inc now has $25.38B valuation. The stock decreased 1.15% or $0.48 during the last trading session, reaching $41.12. About 152,543 shares traded. Sun Life Financial Inc. (NYSE:SLF) has risen 28.61% since June 18, 2017 and is uptrending. It has outperformed by 16.04% the S&P500. Some Historical SLF News: ; 08/05/2018 – SUN LIFE FINANCIAL INC – QTRLY REPORTED EPS $1.09; 03/04/2018 – SUN LIFE FINANCIAL INC – ALIGNING INTERNATIONAL HIGH NET WORTH LIFE INSURANCE BUSINESS WITH ITS SLF ASIA BUSINESS GROUP; 23/03/2018 – Sun Life Financial Closes Below 50-Day Average: Technicals; 02/04/2018 – PBOC SAYS 1-MONTH SLF OFFERED AT 3.9%; 19/04/2018 – Sun Life Building Makes History on Its 100th Anniversary Earning the First Ever BOMA BEST Platinum Certification for a; 03/04/2018 – Sun Life Financial strengthens its Asia high net worth insurance business; 02/04/2018 – China c.bank says it raised interest rates on SLF loans in March; 03/04/2018 – SUN LIFE FINANCIAL INC – THERE ARE NO CHANGES TO SLF INTERNATIONAL OPERATIONS, PRODUCTS OR SERVICES RESULTING FROM ANNOUNCEMENT; 08/05/2018 – Sun Life 1Q Net C$693M; 02/04/2018 – CHINA C.BANK: LENT 32.34 BLN YUAN FOR 1-MTH PERIOD VIA SLF IN MARCH

The stock of Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) is a huge mover today! The stock decreased 6.19% or $0.18 during the last trading session, reaching $2.73. About 140,644 shares traded. Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) has declined 42.74% since June 18, 2017 and is downtrending. It has underperformed by 55.31% the S&P500. Some Historical SNOA News: ; 17/04/2018 – SONOMA PHARMACEUTICALS – 4 APPROVALS ENCOMPASS HYPOCHLOROUS ACID-BASED PRODUCTS FOR TREATMENT OF ACNE AS WELL AS ANTI-FUNGAL INDICATIONS; 05/04/2018 – Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy Gel; 27/03/2018 Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution; 08/05/2018 – Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer; 17/04/2018 – Sonoma Pharmaceuticals Receives Four New UAE Regulatory Approvals that Include Acne and Anti-Fungal ProductsThe move comes after 5 months negative chart setup for the $16.85 million company. It was reported on Jun, 18 by Barchart.com. We have $2.57 PT which if reached, will make NASDAQ:SNOA worth $1.01M less.

Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in the United States, Latin America, Europe, and internationally. The company has market cap of $16.85 million. The firm offers Microcyn line of products that are based on electrically charged oxychlorine small molecules designed to target a range of pathogens, such as viruses, fungi, and spores, as well as bacteria, including antibiotic-resistant strains. It currently has negative earnings. The Company’s products also include Celacyn, a prescription hypochlorous acid based scar management gel; Ceramax Skin Barrier Cream to manage dry itchy skin, minor skin irritations, rashes, and inflammation; Mondoxyne, a prescription oral tetracycline antibiotic for the treatment of various bacterial infections; Alevicyn, a prescription hypochlorous acid based atopic dermatitis product line to reduce itch and pain associated with various dermatoses; and SebuDerm, a prescription topical gel for the management of burning, itching, and scaling in seborrhea and seborrheic dermatitis.

More notable recent Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) news were published by: Seekingalpha.com which released: “Sonoma Pharmaceuticals, Inc.’s (SNOA) CEO James Schutz on Q4 2018 Results – Earnings Call Transcript” on June 14, 2018, also Nasdaq.com with their article: “Mid-Day Market Update: Destination Maternity Climbs After Q1 Results; Tailored Brands Shares Slide” published on June 14, 2018, Nasdaq.com published: “Mid-Afternoon Market Update: Sonoma Pharmaceuticals Falls Following Q4 Miss; Teligent Shares Surge” on June 14, 2018. More interesting news about Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) were released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid …” published on June 15, 2018 as well as Nasdaq.com‘s news article titled: “U.SK, dermatology arm of Brazilian NC Group, and Sonoma Pharmaceuticals Enter into License Agreement for …” with publication date: June 05, 2018.

Among 12 analysts covering Sun Life Financial Inc. (NYSE:SLF), 6 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. Sun Life Financial Inc. had 26 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Overweight” rating by Barclays Capital given on Monday, March 7. The company was upgraded on Monday, July 10 by Bank of America. Bank of America initiated the shares of SLF in report on Wednesday, August 24 with “Underperform” rating. IBC upgraded the shares of SLF in report on Thursday, February 11 to “Sector Outperform” rating. The firm earned “Equal-Weight” rating on Monday, November 13 by Morgan Stanley. The stock of Sun Life Financial Inc. (NYSE:SLF) has “Hold” rating given on Wednesday, July 27 by Jefferies. The firm earned “Outperform” rating on Thursday, September 10 by Macquarie Research. The stock of Sun Life Financial Inc. (NYSE:SLF) has “Equal-Weight” rating given on Thursday, October 5 by Morgan Stanley. The stock of Sun Life Financial Inc. (NYSE:SLF) earned “Sector Perform” rating by RBC Capital Markets on Friday, February 17. The stock has “Buy” rating by Argus Research on Wednesday, December 23.

Barometer Capital Management Inc decreased Reinsurance Group Of America Inc (NYSE:RGA) stake by 2,350 shares to 3,100 valued at $477,000 in 2018Q1. It also reduced Sherwin (NYSE:SHW) stake by 19,300 shares and now owns 13,900 shares. Union Pacific Corp (NYSE:UNP) was reduced too.

Another recent and important Sun Life Financial Inc. (NYSE:SLF) news was published by Fool.ca which published an article titled: “TFSA Investors: 2 Stocks to Start a Canadian Dividend Portfolio” on May 30, 2018.

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Ratings Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>